Metformin Hcl Ir Tablets Suppliers & Bulk Manufacturers
Available Forms: IR Tablets
Available Strengths: 500 mg, 850 mg, 1000 mg
Reference Brands: Glucophage®, Riomet®, Sandoz Metformin®(US & EU)
Category:
Diabetes
Metformin IR reduces hepatic glucose production and improves insulin sensitivity by activating AMP-activated protein kinase (AMPK). It does not stimulate insulin secretion, reducing the risk of hypoglycemia. Benefits include effective blood glucose control, weight neutrality, and cardiovascular protection, making it a first-line therapy for type 2 diabetes management.
Metformin Hcl IR tablets is available in IR Tablets
and strengths such as 500 mg, 850 mg, 1000 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Metformin Hcl IR tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Metformin Hcl IR tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Metformin Immediate-Release (IR) Tablets are widely approved in the USA (ANDA pathway) and EU (generic via Article 10) for type 2 diabetes management. Regulatory submissions must include full bioequivalence studies, stability data, and impurity profiling per ICH guidelines. EU submissions may also require environmental risk assessments. In the US, products must comply with USP standards and be supported by Drug Master Files (DMFs). EU dossiers may follow ASMF or CEP formats. Metformin IR is also listed under the WHO Essential Medicines List. To source compliant dossiers or manufacturing partners, visit Pharmatradz.com for global B2B pharma solutions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing